Brendolan A - Search Results

1

Erythropoeitin dose variation in different facilities in different countries and its relationship to drug resistance.

Greenwood RN, Ronco C, Gastaldon F, Brendolan A, Homel P, Usvyat L, Bruno L, Carter M, Levin NW. Greenwood RN, et al. Among authors: brendolan a. Kidney Int Suppl. 2003 Nov;(87):S78-86. doi: 10.1046/j.1523-1755.64.s87.12.x. Kidney Int Suppl. 2003. PMID: 14531778 Free article.

2

Blood and dialysate flow distributions in hollow-fiber hemodialyzers analyzed by computerized helical scanning technique.

Ronco C, Brendolan A, Crepaldi C, Rodighiero M, Scabardi M. Ronco C, et al. Among authors: brendolan a. J Am Soc Nephrol. 2002 Jan;13 Suppl 1:S53-61. J Am Soc Nephrol. 2002. PMID: 11792763

3

Hemodialyzer: from macro-design to membrane nanostructure; the case of the FX-class of hemodialyzers.

Ronco C, Bowry SK, Brendolan A, Crepaldi C, Soffiati G, Fortunato A, Bordoni V, Granziero A, Torsello G, La Greca G. Ronco C, et al. Among authors: brendolan a. Kidney Int Suppl. 2002 May;(80):126-42. doi: 10.1046/j.1523-1755.61.s80.23.x. Kidney Int Suppl. 2002. PMID: 11982827 Free article.

4

Flow distribution and cross filtration in hollow fiber hemodialyzers.

Ronco C, Brendolan A, Crepaldi C, Gastaldon F, Levin NW. Ronco C, et al. Among authors: brendolan a. Contrib Nephrol. 2002;(137):120-8. doi: 10.1159/000060238. Contrib Nephrol. 2002. PMID: 12101944 No abstract available.

5

Noninvasive transcutaneous access flow measurement before and after hemodialysis: impact of hematocrit and blood pressure.

Ronco C, Brendolan A, Crepaldi C, D'Intini V, Sergeyeva O, Levin NW. Ronco C, et al. Among authors: brendolan a. Blood Purif. 2002;20(4):376-9. doi: 10.1159/000063107. Blood Purif. 2002. PMID: 12169848

6

High-volume hemofiltration in sepsis. Theoretical basis and practical application.

Reiter K, D'Intini V, Bordoni V, Baldwin I, Bellomo R, Tetta C, Brendolan A, Ronco C. Reiter K, et al. Among authors: brendolan a. Nephron. 2002 Oct;92(2):251-8. doi: 10.1159/000063325. Nephron. 2002. PMID: 12218300 Review. No abstract available.

7

Flow dynamic characteristics of DIAPES hemodialyzers.

Brendolan A, Tetta C, Granziero A, D'Intini V, Bordoni V, Ronco C. Brendolan A, et al. Contrib Nephrol. 2003;(138):27-36. Contrib Nephrol. 2003. PMID: 12463143 No abstract available.

8

Do circulating cytokines really matter in sepsis?

Tetta C, Bellomo R, D'Intini V, De Nitti C, Inguaggiato P, Brendolan A, Ronco C. Tetta C, et al. Among authors: brendolan a. Kidney Int Suppl. 2003 May;(84):S69-71. doi: 10.1046/j.1523-1755.63.s84.40.x. Kidney Int Suppl. 2003. PMID: 12694313 Free article. Review.

9

Monocyte apoptosis in uremia is normalized with continuous blood purification modalities.

D'Intini V, Bordoni V, Bolgan I, Bonello M, Brendolan A, Crepaldi C, Gastaldon F, Levin NW, Bellomo R, Ronco C. D'Intini V, et al. Among authors: brendolan a. Blood Purif. 2004;22(1):9-12. doi: 10.1159/000074918. Blood Purif. 2004. PMID: 14732806

10

The role of extracorporeal therapies in sepsis.

Ronco C, Inguaggiato P, D'Intini V, Cole L, Bellomo R, Poulin S, Bordoni V, Crepaldi C, Gastaldon F, Brendolan A, Trairak P, Khajohn T. Ronco C, et al. Among authors: brendolan a. J Nephrol. 2003 Nov-Dec;16 Suppl 7:S34-41. J Nephrol. 2003. PMID: 14733299 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

233 results

Search Page